baltimore conference logo
  • MJHLS Brand Logo

© 2021 MJH Life Sciences™ , Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways. All rights reserved.

Examining TKI Combinations in Advanced RCC - Episode 1

Frontline Treatment of Advanced Renal Cell Carcinoma

March 30, 2021
Robert J. Motzer, MD

,
Toni K. Choueiri, MD

,
Thomas E. Hutson, DO, PharmD

The panelists discuss frontline treatment for renal cell carcinoma, highlighting TKIs targeting VEGFR and the mechanisms of action for currently approved therapeutics.

Now Viewing
EP. 1: Frontline Treatment of Advanced Renal Cell Carcinoma